Bausch Health Poland Sp. z o.o.
PolandAll drugs from this manufacturer
-
The medicine is used to treat adults and children and adolescents (over 10 years of age and weighing more than 40 kg) with relapsing-remitting multiple sclerosis.
Dosage form: tablets, film-coated
Active substance Dosage teriflunomide 14 mg ATC: L04AK02
-
The medicine is used to treat relapsing-remitting multiple sclerosis in patients aged 13 years and older. It helps prevent the immune system from damaging the brain and spinal cord, which may slow the progression of the disease.
Dosage form: capsules, hard, intestinal
Active substance Dosage dimethyl fumarate 120 mg ATC: L04AX07
-
The medicine is used to treat relapsing-remitting multiple sclerosis in patients aged 13 years and older.
Dosage form: capsules, hard, intestinal
Active substance Dosage dimethyl fumarate 240 mg ATC: L04AX07
-
The medicine is used in adults to relieve the symptoms of osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis. It helps to reduce pain, swelling, redness, and inflammation.
Dosage form: tablets, modified release
Active substance Dosage naproxen 500 mg esomeprazole 20 mg ATC: M01AE52
-
The medicine is used in the treatment of depression (major depressive episodes) and various anxiety disorders, such as social phobia, generalized anxiety disorder, obsessive-compulsive disorder, or anxiety disorders with panic attacks.
Dosage form: tablets, film-coated
Active substance Dosage escitalopram 10 mg ATC: N06AB10
-
The medicinal product is used in the treatment of depression (major depressive episodes) and various anxiety disorders, such as social phobia, generalized anxiety disorder, obsessive-compulsive disorder, or panic attacks with or without agoraphobia.
Dosage form: tablets, film-coated
Active substance Dosage escitalopram 20 mg ATC: N06AB10
-
The medicine is used in adults and children and adolescents (over 10 years of age) for the treatment of relapsing-remitting multiple sclerosis (MS), particularly in individuals for whom other medicines have not worked or in whom the disease is progressing rapidly and severely.
Dosage form: capsules, hard
Active substance Dosage fingolimod hydrochloride 0.56 mg ATC: L04AE01
-
The medicine is used to treat loss of appetite (anorexia) or weight loss resulting from cancer or acquired immunodeficiency syndrome (AIDS).
Dosage form: suspension, oral
Active substance Dosage megestrol acetate 40 mg ATC: L02AB01
-
The medicine is used to balance blood sugar levels in adult patients with type 2 diabetes. It helps increase the concentration of insulin released after a meal and reduces the amount of sugar produced by the body.
Dosage form: tablets, film-coated
Active substance Dosage sitagliptin 54.47 mg metformin hydrochloride 850 mg ATC: A10BD07
-
Mifomet is used in adult patients with type 2 diabetes to balance blood sugar levels. It helps increase the amount of insulin released after a meal and reduces the amount of sugar produced by the body.
Dosage form: tablets, film-coated
Active substance Dosage sitagliptin 54.47 mg metformin hydrochloride 1000 mg ATC: A10BD07
-
The medicine is used in adult patients with mild to moderately severe Alzheimer's-type dementia and in individuals with dementia related to Parkinson's disease.
Dosage form: capsules, hard
Active substance Dosage rivastigmine hydrogen tartrate 2.4 mg ATC: N06DA03
-
The medicine is used in adult patients to relieve the symptoms of mild to moderately severe Alzheimer's-type dementia and dementia associated with Parkinson's disease.
Dosage form: capsules, hard
Active substance Dosage rivastigmine hydrogen tartrate 4.8 mg ATC: N06DA03
-
The medicine is used in adult patients to relieve the symptoms of mild to moderate Alzheimer's-type dementia and dementia associated with Parkinson's disease.
Dosage form: capsules, hard
Active substance Dosage rivastigmine hydrogen tartrate 7.2 mg ATC: N06DA03
-
The medicine is used in adult patients for the treatment of mild to moderately severe Alzheimer's-type dementia and in the treatment of dementia in people with Parkinson's disease.
Dosage form: capsules, hard
Active substance Dosage rivastigmine hydrogen tartrate 9.6 mg ATC: N06DA03
-
The medicine is used to dissolve cholesterol gallstones (up to 15 mm in diameter), in the treatment of primary biliary cirrhosis, and other liver and bile duct diseases. It also helps in the treatment of gastritis caused by bile reflux, in cases of intrahepatic cholestasis in pregnant women, and in the prevention of gallstones in individuals following bariatric surgery or rapid weight loss.
Dosage form: capsules, hard
Active substance Dosage ursodeoxycholic acid 150 mg ATC: A05AA02
-
It is used in the treatment of schizophrenia and moderate to severe manic episodes. It also helps to prevent the recurrence of these symptoms in people with bipolar disorder.
Dosage form: tablets, dispersible in the oral cavity
Active substance Dosage olanzapine 5 mg ATC: N05AH03
-
The medicine is used in the treatment of schizophrenia and moderate to severe manic episodes. It also helps to prevent the recurrence of these symptoms in people with bipolar disorder.
Dosage form: tablets, dispersible in the oral cavity
Active substance Dosage olanzapine 10 mg ATC: N05AH03
-
The medicine is used in the treatment of schizophrenia and moderate to severe manic episodes. It also helps to prevent the recurrence of these symptoms in people with bipolar disorder.
Dosage form: tablets, dispersible in the oral cavity
Active substance Dosage olanzapine 15 mg ATC: N05AH03
-
The medicine is used in the treatment of schizophrenia and moderate to severe manic episodes. It also helps to prevent the recurrence of these symptoms in people with bipolar disorder.
Dosage form: tablets, dispersible in the oral cavity
Active substance Dosage olanzapine 20 mg ATC: N05AH03